PPIB and Alzheimer disease: Overall, the study findings demonstrated that the Αβ (1–40) antibody that is normally hampered by the BBB can efficiently and safely enter the brain parenchyma and bind to Aβ plaques of the 5XFAD mouse model of AD by FUS + MBs-mediated BBB opening with the proposed optimized protocol.